Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!

Oliver Kepp; Guido Guido Kroemer

doi:10.1080/2162402x.2020.1846358

Back

Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!

Editorial Material 2020 en

Abstract

1 min read

Anticancer immunotherapy has revolutionized the clinical routine of antineoplastic regimen offering novel treatment options for patients with advanced and therapy-resistant disease. In particular i...

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now

Georgina V. Long, Alexander M. Menzies, Richard A Scolyer

Article2017

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma

Tuba N. Gide, James S. Wilmott, Richard A Scolyer, Georgina V. Long

Preprint2023

Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma

Tuba N. Gide, James S. Wilmott, Richard A Scolyer, Georgina V. Long

Preprint2023

Data from Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma

Tuba N. Gide, James S. Wilmott, Richard A Scolyer, Georgina V. Long

Article2023

Conventional type 1 dendritic cells (cDC1) in cancer immunity

Peng Liu, Liwei Zhao, Guido Guido Kroemer, Oliver Kepp